Virtual: Feline Diabetes Masterclass: Safety & Efficacy Data of SGLT-2 Inhibitors

This session is livestreamed from VMX Orlando. The most successful oral treatment for feline diabetes is currently sodium glucose transporter 2 (SGLT-2) inhibitors. During this lecture, we will reveal safety and efficacy data regarding velagliflozin, an SGLT-2 inhibitor recently studied in cats. This class of drugs will likely change the landscape of feline diabetes management over the next few years. Presented by: Boehringer Ingelheim